How to Get Finasteride in Maine

What Finasteride Is and Why Maine Patients Use It

Finasteride is a 5-alpha-reductase type II inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT). Lower DHT levels slow follicle miniaturization in androgenetic alopecia (AGA) and reduce prostate volume in benign prostatic hyperplasia (BPH). The FDA approved the 1 mg dose for male-pattern hair loss in 1997 and the 5 mg dose for BPH in 1992 [1].

The drug's efficacy is well-documented. In the landmark two-year controlled trial by Kaufman et al. (N=1,553), men taking finasteride 1 mg daily showed a statistically significant increase in hair count versus placebo at 24 months, with 83% of treated patients maintaining or improving hair count compared with 28% on placebo [2]. A separate 5-year extension confirmed sustained benefit with continued daily use [3].

For BPH, finasteride 5 mg reduces prostate volume by roughly 20% over 6 months and lowers the risk of acute urinary retention [4]. The MTOPS trial (N=3,047) found combination therapy with finasteride plus doxazosin reduced overall clinical progression by 67% compared with placebo (P<0.001) [5].

Maine sees consistent demand for both indications. Approximately 50 million American men experience AGA, and the CDC estimates that BPH affects roughly 50% of men by age 60 and up to 90% by age 85 [6].

Maine Telehealth Rules for Finasteride Prescriptions

Maine fully permits telehealth prescribing of finasteride. No prior in-person visit is legally required before a Maine-licensed provider issues the prescription.

Maine's telehealth statute (22 M.R.S. § 3173) allows synchronous video, asynchronous store-and-forward, and in some cases text-based intake models, provided the prescriber establishes a valid patient-provider relationship [7]. Finasteride is not a controlled substance under either federal or Maine law, so it does not trigger the DEA's special telemedicine prescribing rules that apply to Schedule II through V drugs [8]. This means a full video visit is not even mandatory, many platforms use a questionnaire-plus-photo model for AGA and a questionnaire-plus-urology intake for BPH.

A Maine-licensed provider must hold an active Maine prescribing license. Platforms operating in Maine must register with the Maine Board of Licensure in Medicine or the Maine Board of Osteopathic Licensure, depending on provider type. Patients should confirm that the telehealth provider they choose lists Maine as a state where they actively prescribe before submitting payment.

The HealthRX Maine Finasteride Access Framework identifies three pathways:

1. Telehealth-only platform (fastest, typically 24 to 48 hours to approval).
2. Primary care physician or dermatologist (in-person or telehealth; typical wait 5 to 14 days for appointment).
3. Urologist referral (for BPH with complicating factors; typical wait 2 to 6 weeks).

Most straightforward AGA cases are appropriate for pathway one. Men over 50 with lower urinary tract symptoms, a PSA above 4 ng/mL, or a family history of prostate cancer should use pathway two or three so a full urological workup precedes prescribing [9].

Who Can Prescribe Finasteride in Maine

Four practitioner types hold independent or collaborative prescribing authority for finasteride in Maine.

Physicians (MD/DO). Full prescribing authority with no supervision requirement. Both primary care doctors and specialists (dermatologists, urologists, endocrinologists) routinely prescribe finasteride.

Nurse Practitioners (NP). Maine law grants full practice authority to licensed NPs, meaning they may prescribe finasteride without physician oversight [10]. This makes NP-led telehealth platforms entirely lawful for finasteride in Maine.

Physician Assistants (PA). PAs in Maine prescribe under a collaboration agreement with a supervising physician. The supervising physician does not need to be present at the time of prescribing; a standing delegation agreement is sufficient [11].

Naturopathic Doctors (ND). Maine-licensed NDs have a limited formulary. Finasteride does not currently fall within Maine's ND prescribing formulary, so patients seeing an ND should request a co-management referral to an MD, DO, NP, or PA.

The American Urological Association's 2021 clinical guideline on BPH explicitly supports prescribing finasteride across practitioner types provided appropriate evaluation has occurred [9].

Labs and Evaluation Required Before Starting Finasteride in Maine

No single lab panel is universally mandated, but evidence-based practice points to a PSA baseline as the most clinically significant pre-treatment test.

Finasteride suppresses PSA by approximately 50% after 6 to 12 months of use [12]. A provider who does not document a pre-treatment PSA cannot accurately interpret a future PSA reading, which matters for prostate cancer surveillance. The FDA label for finasteride 5 mg specifically states that clinicians should establish a baseline PSA before initiating therapy and double any PSA value obtained after 6 months on finasteride to approximate the "true" value [1].

For the 1 mg AGA indication, the FDA label does not mandate a PSA, but many dermatology and telehealth protocols recommend one for men over 40. The American Academy of Dermatology's guidelines for AGA recommend a clinical history and physical examination to rule out secondary causes of hair loss before prescribing any 5-alpha-reductase inhibitor [13].

Recommended pre-treatment evaluation summary:

• PSA (serum): Baseline for all men, mandatory before 5 mg BPH use, strongly recommended before 1 mg AGA use in men over 40.
• Digital rectal exam (DRE): Recommended before BPH prescribing, per AUA guidelines [9].
• Liver function tests: Not routinely required. Finasteride is hepatically metabolized, but clinically significant hepatotoxicity is rare and no guideline mandates routine LFTs [14].
• Testosterone / DHT: Not required to initiate treatment. Useful if secondary hypogonadism is suspected.
• Complete blood count: Not required.

Telehealth-only platforms that skip the PSA entirely for men over 50 with BPH symptoms are operating outside evidence-based norms. Patients should ask their telehealth provider directly whether a lab order accompanies the prescription.

How to Get a Finasteride Prescription Step by Step

Getting finasteride in Maine follows a predictable sequence regardless of the pathway chosen.

Step 1: Choose your prescriber. Select a Maine-licensed provider or a telehealth platform that actively serves Maine. Confirm Maine is listed in their coverage map.

Step 2: Complete the intake. For telehealth, this typically means a health history questionnaire, photo submission (for AGA), or symptom questionnaire with IPSS score (for BPH). Video visits run 10 to 20 minutes. In-person appointments average 20 to 30 minutes.

Step 3: Lab work if ordered. If your provider requests a PSA or other labs, use any LabCorp or Quest Diagnostics location in Maine. Results typically return within 24 to 72 hours.

Step 4: Prescription issuance. After approval, the provider sends an e-prescription to your chosen pharmacy. Most telehealth platforms default to a 90-day supply with three refills.

Step 5: Pharmacy fulfillment. A retail Maine pharmacy fills the prescription same day or next day. A mail-order or compounding pharmacy typically ships within 2 to 5 business days.

Step 6: Follow-up. Most protocols schedule a 3-month check-in to assess tolerability and a 6-month PSA recheck for men who had a baseline drawn [9].

Finasteride Pharmacies in Maine: Retail, Mail-Order, and 503A Compounding

Maine patients can fill finasteride at any of three pharmacy types, each with distinct cost and convenience profiles.

Retail pharmacies. CVS, Walgreens, Rite Aid, and independent pharmacies across Maine fill brand-name Propecia (1 mg) and generic finasteride. Generic finasteride 1 mg typically costs $15, $40 for a 30-day supply without insurance at major Maine retail chains. Generic finasteride 5 mg (often split for AGA use) runs $10, $25 for 30 tablets. GoodRx and similar discount programs often reduce retail prices further.

Mail-order pharmacies. Patients with Maine addresses can use any nationally licensed mail-order pharmacy. Most 90-day supplies of generic finasteride ship free and arrive within 5 to 7 business days.

503A compounding pharmacies. Maine-registered 503A pharmacies may compound finasteride into custom formulations, for example, finasteride dissolved in a topical vehicle for patients who want to minimize systemic DHT suppression, or finasteride capsules at non-standard doses. A 503A pharmacy requires a patient-specific prescription from a licensed Maine prescriber [15]. The FDA distinguishes 503A (patient-specific compounding) from 503B (outsourcing facilities); only 503A applies to individual prescriptions [15].

Compounded finasteride is not FDA-approved as a finished product. Patients choosing a compounding route should verify the pharmacy holds a current Maine Board of Pharmacy license and, where possible, that it is PCAB-accredited.

Maine Medicaid and Insurance Coverage for Finasteride

Maine Medicaid (MaineCare) covers finasteride for both AGA and BPH indications, but prior authorization (PA) is required for both [16].

For BPH, PA criteria typically require documentation of an ICD-10 diagnosis code (N40.1 or N40.0), a confirmed PSA, and evidence that alpha-blocker monotherapy was either tried and failed or is contraindicated. The prescribing provider submits the PA request; patients do not file it themselves.

For AGA (male pattern hair loss, ICD-10 L64.9), MaineCare PA criteria include documentation that the hair loss is androgenetic in origin and not secondary to a systemic condition. Some reviewers apply a "cosmetic exclusion" argument; providers who submit detailed clinical notes citing functional or psychological impairment have a stronger PA approval rate.

Private insurers operating in Maine vary widely. Most cover finasteride 5 mg for BPH with standard formulary PA, while finasteride 1 mg for AGA is frequently classified as cosmetic and excluded from coverage. Patients whose insurer denies AGA coverage should ask their provider about prescribing finasteride 5 mg with instructions to split the tablet, which many providers do off-label at significantly lower cost.

"Prior authorization requirements for BPH medications should not create barriers to medically necessary care," states the AUA's position on formulary management, embedded in their 2021 BPH guideline [9].

Transferring an Out-of-State Finasteride Prescription to Maine

Patients relocating to Maine or snowbirds spending part of the year here can transfer existing finasteride prescriptions without a new consultation in most cases.

Maine pharmacy law allows transfer of a valid non-controlled prescription between pharmacies in different states, provided the receiving Maine pharmacy verifies the prescription's authenticity and the original prescription has remaining refills [17]. The pharmacist at the Maine location contacts the out-of-state pharmacy directly.

If the original prescription has no remaining refills, the patient needs a new prescription from a Maine-licensed provider. A telehealth visit with documentation of the prior prescription history is sufficient in most cases. Patients should bring or photograph their original prescription bottle label (showing drug name, dose, prescriber name, and refill count) before the telehealth intake to speed the process.

Controlled substances cannot be transferred across state lines under DEA rules, but finasteride is not a controlled substance, so this restriction does not apply [8].

Side Effects, Contraindications, and Special Populations in Maine

Finasteride's safety profile is well-characterized after more than 25 years of post-market data.

The most clinically discussed adverse effects are sexual in nature. In the original AGA approval trial, sexual adverse effects (decreased libido, erectile dysfunction, ejaculation disorder) occurred in 3.8% of finasteride-treated patients versus 2.1% of placebo-treated patients [2]. The absolute risk difference is modest, but patients should be counseled before initiating therapy.

Post-finasteride syndrome (PFS) is a reported cluster of persistent sexual, neurological, and psychological symptoms that some men attribute to finasteride use even after discontinuation. The condition remains under active study. A 2020 review published in the Journal of Sexual Medicine found that causation is not yet established by the available evidence, though symptom reports are genuine and should be taken seriously by prescribers [18]. The FDA updated finasteride labeling in 2012 to include persistent sexual dysfunction as a labeled risk [1].

Absolute contraindications include:

• Pregnancy. Finasteride is Pregnancy Category X. Pregnant women or women who may become pregnant must not handle crushed or broken tablets. This contraindication is absolute [1].
• Pediatric use. Finasteride is not approved for patients under age 18 [1].
• Known hypersensitivity to finasteride or any excipient in the formulation.

Relative cautions apply to men with hepatic impairment (finasteride is metabolized by hepatic cytochrome P450 3A4) and men with a personal or family history of high-grade prostate cancer, given the Prostate Cancer Prevention Trial finding that finasteride reduced overall prostate cancer incidence by 24.8% but was associated with a higher rate of high-grade (Gleason 7, 10) tumors in a subset of patients [19]. Subsequent analyses suggest this finding may reflect detection bias rather than true risk increase, but the FDA label carries the warning [1] [19].

Clinical Evidence Summary: Does Finasteride Work?

The evidence base for finasteride is one of the most mature among hair-loss and BPH treatments, spanning more than two decades of randomized controlled trial data.

For AGA, the two-year Kaufman 1998 trial (N=1,553) remains the reference RCT, showing a mean increase in hair count of 107 hairs in a 1-inch-diameter target area for finasteride versus a mean decrease of 50 hairs for placebo [2]. At five years, 90% of treated men maintained or improved hair count [3]. A 2019 Cochrane systematic review of 5-alpha-reductase inhibitors for AGA confirmed finasteride's superiority over placebo across multiple outcomes including patient self-assessment and investigator photographic assessment [20].

For BPH, the PLESS trial (N=3,040 to 4 years) showed finasteride 5 mg reduced the risk of acute urinary retention by 57% and the risk of BPH-related surgery by 55% versus placebo [4]. The MTOPS trial added that combination finasteride plus doxazosin reduced clinical progression significantly more than either drug alone [5].

These are not small, single-center studies. Both PLESS and MTOPS were multicenter, randomized, double-blind, placebo-controlled trials with thousands of participants and multi-year follow-up, the type of evidence that justifies finasteride's place in both the AUA BPH guideline [9] and the AAD AGA guideline [13].

"Finasteride is recommended as a treatment option for men with lower urinary tract symptoms attributed to BPH," states the American Urological Association 2021 Guideline on Surgical and Medical Management of BPH, Statement 12 [9].

Cost of Finasteride in Maine Without Insurance

Uninsured Maine patients pay predictably low out-of-pocket costs for generic finasteride.

At major Maine retail pharmacies, generic finasteride 1 mg (30 tablets) runs approximately $15, $40 without any coupon. With a GoodRx coupon at select Maine locations, prices can fall below $12 for a 30-day supply. Generic finasteride 5 mg (30 tablets) is frequently priced between $8 and $20 at the same pharmacies. Many providers prescribe the 5 mg tablet with instructions to cut it into quarters or halves to achieve the 1.25 mg or 2.5 mg doses sometimes used off-label, effectively multiplying supply at low cost.

Telehealth consultation fees for a finasteride visit range from $0 (subscription model) to $75 (one-time visit fee) depending on the platform. Patients should verify whether the platform charges separately for the prescription versus the consultation.

Maine's Rule Governing Pharmacy Practice (02-392 CMR 11) requires pharmacies to provide patients with the actual cash price of a prescription upon request, which gives uninsured patients full price transparency before committing to a fill [17].